FILE PHOTO: The logo of BioNTech is pictured at Biontech’s research laboratory for individualised vaccines against cancer in Mainz, Germany, July 27, 2023. REUTERS/Wolfgang Rattay/File Photo Post navigation Pfizer, BioNtech say flu-COVID shot generates strong immune response in trial